SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-08-003625
Filing Date
2008-05-12
Accepted
2008-05-12 16:02:15
Documents
6
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 CRITICAL THERAPEUTICS, INC. b69705cte10vq.htm 10-Q 604646
2 EX-10.2 AMENDMENT NO. 1 TO TERMINATION OF LEASE AND VOLUNTARY SURRENDER OF PREMI b69705ctexv10w2.htm EX-10.2 6724
3 EX-31.1 SECTION 302 CERTIFICATION OF CEO b69705ctexv31w1.htm EX-31.1 8228
4 EX-31.2 SECTION 302 CERTIFICATION OF CFO b69705ctexv31w2.htm EX-31.2 8262
5 EX-32.1 SECTION 906 CERTIFICATION OF CEO b69705ctexv32w1.htm EX-32.1 3294
6 EX-32.2 SECTION 906 CERTIFICATION OF CFO b69705ctexv32w2.htm EX-32.2 3388
  Complete submission text file 0000950135-08-003625.txt   635928
Mailing Address 60 WESTVIEW STREET LEXINGTON MA 02421
Business Address 60 WESTVIEW STREET LEXINGTON MA 02421 781-402-5700
CRITICAL THERAPEUTICS INC (Filer) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50767 | Film No.: 08823365
SIC: 2834 Pharmaceutical Preparations